Mochida Pharmaceutical Co.,Ltd., First Half Ordinary Profit Increases by 1%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Nov 1, 2024 2:00 pm JST Earnings

4534 Mochida Pharmaceutical Co.,Ltd. 【J-GAAP】

Earnings Report

Mochida Pharmaceutical Co.,Ltd. <4534> [TSE-P] announced its financial results in the afternoon session on November 1st (14:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) was 4.07 billion yen, a 0.6% increase compared to the same period last year. The progress rate against the 7.7 billion yen full-year plan was 53.0%, it was below the five-year average of 60.0%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to expand by 82.5% from the same period last year, reaching 3.62 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit grew by 17.2% from the same period last year, reaching 1.71 billion yen. The operating profit margin improved from 5.8% in the same period last year to 6.2%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	53,200	5,279	5,443	3,923	104.6	59.9	Nov 4, 2022	J-GAAP
Apr - Sep, 2023	49,476	3,952	4,053	2,838	78.4	67.1	Nov 2, 2023	J-GAAP
Apr - Sep, 2024	51,096	3,793	4,079	2,825	79.7	53.0	Nov 1, 2024	J-GAAP
YoY	+3.3%	-4.0%	+0.6%	-0.5%	+1.7%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Guidance	ー	ー	ー	ー	－	40	May 13, 2024	J-GAAP
Apr - Sep, 2024 Results	51,096	3,793	4,079	2,825	79.7	40	Nov 1, 2024	J-GAAP
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	53,409	1,850	1,984	1,709	47.7	40	May 13, 2024	J-GAAP
Oct - Mar, 2024 Guidance	54,904	3,707	3,621	2,775	78.3	40	Nov 1, 2024	J-GAAP
YoY	+2.8%	+100.4%	+82.5%	+62.4%	+64.2%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	103,261	8,507	9,085	6,649	178.9	80	May 15, 2023	J-GAAP
Mar, 2024	102,885	5,802	6,037	4,547	126.8	80	May 13, 2024	J-GAAP
Mar, 2025 Guidance	106,000	7,500	7,700	5,600	158.0	80	May 13, 2024	J-GAAP
YoY	+3.0%	+29.3%	+27.5%	+23.2%	+24.6%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	24,729	1,437	1,461	1,150	31.8	5.8	Nov 2, 2023	J-GAAP
Oct - Dec, 2023	28,742	1,839	2,006	1,606	44.6	6.4	Feb 5, 2024	J-GAAP
Jan - Mar, 2024	24,667	11	-22	103	2.9	0.0	May 13, 2024	J-GAAP
Apr - Jun, 2024	25,407	2,189	2,367	1,554	43.9	8.6	Aug 2, 2024	J-GAAP
Jul - Sep, 2024	25,689	1,604	1,712	1,271	35.9	6.2	Nov 1, 2024	J-GAAP
YoY	+3.9%	+11.6%	+17.2%	+10.5%	+12.9%